Turkish Journal of Physical Medicine and Rehabilitation

Botulinum toxin type A treatment for persistent neuropathic pain in the soles after cervical spinal cord injury: A case report

Alper Mengi 1 ,Bengi Gül Türk 2 ,Ugur Uygunoglu 2
1 Department of Pain Management, Sultan 1st Murat State Hospital, Edirne, Türkiye
2 Department of Neurology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Türkiye
DOI : 10.5606/tftrd.2024.13941 Subcutaneous botulinum toxin type A is recommended for neuropathic pain at the level of spinal cord injury. Herein, we present a 42-year-old female patient who presented to our outpatient clinic with neuropathic pain in the soles for eight years due to cervical longsegment myelitis. The patient had previously received various ineffective oral medications for the symptoms. Botulinum toxin type A was injected subcutaneously into bilateral soles. The patient was evaluated in the first, second, third, fourth, and sixth months after the injection. The daytime and nighttime Visual Analog Scale, Neuropathic Pain Questionnaire, Short Form-36, and Beck Depression Inventory scores improved during follow-up. Keywords : Botulinum toxin, neuropathic pain, pain management, spinal cord injury, treatment